PRM Pharma Launches HEMICLOR, First FDA-Approved Low-Dose Chlorthalidone Tablet
WEST CONSHOHOCKEN, PA — PRM Pharma, LLC has announced the availability of HEMICLOR® (12.5 mg chlorthalidone tablets), the first FDA-approved low-dose formulation of chlorthalidone for the treatment of hypertension in …
PRM Pharma Launches HEMICLOR, First FDA-Approved Low-Dose Chlorthalidone Tablet Read More